Total Payments
$713.25
2024 Payments
$19.06
Companies
19
Transactions
28
Medicare Patients
1,074
Medicare Billing
$152,992
Payment Breakdown by Category
Food & Beverage$658.27 (92.3%)
Education$54.98 (7.7%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $658.27 | 26 | 92.3% |
| Education | $54.98 | 2 | 7.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $126.03 | 1 | $0 (2019) |
| Melinta Therapeutics, LLC | $101.51 | 4 | $0 (2020) |
| ViiV Healthcare Company | $71.76 | 4 | $0 (2018) |
| Paratek Pharmaceuticals, Inc. | $57.61 | 1 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $48.59 | 3 | $0 (2019) |
| Theravance Biopharma, Inc. | $41.27 | 2 | $0 (2018) |
| Medtronic, Inc. | $37.45 | 1 | $0 (2023) |
| Janssen Products, LP | $29.99 | 1 | $0 (2018) |
| Astellas Pharma US Inc | $24.99 | 1 | $0 (2017) |
| INSYS Therapeutics Inc | $24.80 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $19.06 | 1 | Neurelis, Inc. ($19.06) |
| 2023 | $55.93 | 2 | Medtronic, Inc. ($37.45) |
| 2022 | $57.61 | 1 | Paratek Pharmaceuticals, Inc. ($57.61) |
| 2020 | $55.28 | 3 | Melinta Therapeutics, LLC ($21.30) |
| 2019 | $177.18 | 4 | Allergan Inc. ($126.03) |
| 2018 | $299.95 | 15 | Melinta Therapeutics, Inc. ($80.21) |
| 2017 | $48.24 | 2 | Astellas Pharma US Inc ($24.99) |
All Payment Transactions
28 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/30/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: EPILEPSY | ||||||
| 11/15/2023 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: NEUROLOGY | ||||||
| 03/06/2023 | Medtronic, Inc. | SONICISION (Device) | Food and Beverage | In-kind items and services | $37.45 | General |
| Category: Ultrasonic Dissection | ||||||
| 09/28/2022 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $57.61 | General |
| Category: ANTIBIOTIC | ||||||
| 03/13/2020 | Melinta Therapeutics, LLC | Vabomere (Drug), Orbactiv | Food and Beverage | In-kind items and services | $21.30 | General |
| Category: ANTIBIOTICS | ||||||
| 01/13/2020 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: Neurology | ||||||
| 01/10/2020 | Nabriva Therapeutics, plc | Xenleta (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: Antibiotic | ||||||
| 09/30/2019 | Allergan Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $126.03 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/20/2019 | Merck Sharp & Dohme Corporation | CUBICIN RF (Drug), ZERBAXA, SIVEXTRO | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/13/2019 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: Respiratory | ||||||
| 07/02/2019 | TETRAPHASE PHARMACEUTICALS, INC. | Xerava (Drug) | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: Complicated Intra-Abdominal Infections | ||||||
| 06/29/2018 | ViiV Healthcare Company | JULUCA (Drug), TRIUMEQ, TIVICAY | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: HIV | ||||||
| 06/01/2018 | Theravance Biopharma, Inc. | VIBATIV (Drug) | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: Infectious Disease | ||||||
| 05/04/2018 | Melinta Therapeutics, Inc. | Vabomere (Drug) | Food and Beverage | In-kind items and services | $26.22 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 04/26/2018 | INSYS Therapeutics Inc | SYNDROS (Drug) | Food and Beverage | In-kind items and services | $24.80 | General |
| Category: Chemotherapy-Induced Nausea and Vomiting | ||||||
| 04/20/2018 | Merck Sharp & Dohme Corporation | CUBICIN RF (Drug), ZERBAXA, SIVEXTRO | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 04/13/2018 | ViiV Healthcare Company | JULUCA (Drug), TRIUMEQ | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: HIV | ||||||
| 03/23/2018 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $12.47 | General |
| 03/16/2018 | ViiV Healthcare Company | JULUCA (Drug), TRIUMEQ | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: HIV | ||||||
| 03/08/2018 | Melinta Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $26.91 | General |
| 03/07/2018 | Janssen Products, LP | PREZCOBIX (Drug) | Education | In-kind items and services | $29.99 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 03/02/2018 | Janssen Biotech, Inc. | PREZCOBIX (Drug) | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 02/09/2018 | Theravance Biopharma, Inc. | VIBATIV (Drug) | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: Infectious Disease | ||||||
| 01/26/2018 | Melinta Therapeutics, Inc. | Baxdela (Drug) | Food and Beverage | In-kind items and services | $27.08 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 01/12/2018 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 114 | 115 | $19,589 | $11,011 |
| 2022 | 4 | 132 | 206 | $29,984 | $17,314 |
| 2021 | 3 | 126 | 134 | $25,814 | $16,408 |
| 2020 | 8 | 702 | 1,497 | $181,990 | $108,259 |
Total Patients
1,074
Total Services
1,952
Medicare Billing
$152,992
Procedure Codes
19
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 70 | 70 | $12,950 | $7,079 | 54.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 11 | 11 | $2,618 | $1,402 | 53.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 20 | 21 | $2,058 | $1,310 | 63.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 13 | 13 | $1,963 | $1,220 | 62.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 44 | 45 | $10,710 | $6,842 | 63.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 46 | 113 | $11,074 | $6,263 | 56.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 28 | 28 | $5,180 | $2,576 | 49.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 14 | 20 | $3,020 | $1,634 | 54.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 60 | 62 | $14,756 | $10,051 | 68.1% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 45 | 46 | $8,510 | $4,844 | 56.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 21 | 26 | $2,548 | $1,513 | 59.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 224 | 862 | $84,476 | $50,536 | 59.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 118 | 121 | $28,798 | $19,743 | 68.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 144 | 148 | $27,380 | $15,958 | 58.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 66 | 165 | $24,915 | $14,052 | 56.4% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 96 | 138 | $10,626 | $4,404 | 41.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 30 | 36 | $3,060 | $1,919 | 62.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 11 | 14 | $1,890 | $1,157 | 61.2% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 13 | 13 | $845.00 | $490.85 | 58.1% |
About Kristen Facciolo
Kristen Facciolo is a Infectious Disease healthcare provider based in Newark, Delaware. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/19/2012. The National Provider Identifier (NPI) number assigned to this provider is 1487914834.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kristen Facciolo has received a total of $713.25 in payments from pharmaceutical and medical device companies, with $19.06 received in 2024. These payments were reported across 28 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($658.27).
As a Medicare-enrolled provider, Facciolo has provided services to 1,074 Medicare beneficiaries, totaling 1,952 services with total Medicare billing of $152,992. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Location Newark, DE
- Active Since 05/19/2012
- Last Updated 07/21/2017
- Taxonomy Code 207RI0200X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1487914834
Products in Payments
- TEFLARO (Drug) $126.03
- NUZYRA (Drug) $57.61
- JULUCA (Drug) $48.51
- Vabomere (Drug) $47.52
- PREZCOBIX (Drug) $44.61
- VIBATIV (Drug) $41.27
- SONICISION (Device) $37.45
- CUBICIN RF (Drug) $29.29
- Baxdela (Drug) $27.08
- SYNDROS (Drug) $24.80
- TRIUMEQ (Drug) $23.25
- Xenleta (Drug) $19.61
- NOXAFIL (Drug) $19.30
- VALTOCO (Drug) $19.06
- EPIDIOLEX (Drug) $18.48
- Xerava (Drug) $18.27
- Arikayce (Drug) $17.10
- BENLYSTA (Biological) $15.27
- Briviact (Drug) $14.37
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Newark
Dr. Jihad Slim, Md, MD
Infectious Disease — Payments: $2.2M
Infectious Disease $2.2M
Dr. Maria Szabela, Md, MD
Infectious Disease — Payments: $336,664
Infectious Disease $336,664
Sally Hodder, M.d, M.D
Infectious Disease — Payments: $93,382
Infectious Disease $93,382
Shobha Swaminathan, M.d, M.D
Infectious Disease — Payments: $78,788
Infectious Disease $78,788
Wanda Figueroa, M.d, M.D
Infectious Disease — Payments: $13,660
Infectious Disease $13,660
Alexander Stoler, M.d, M.D
Infectious Disease — Payments: $5,931
Infectious Disease $5,931